We have shown in this study that the majority of CRC in our population preferentially overexpress EpCAM over E-cadherin and this favours local tumour progression by conferring more invasive properties to the tumour cells even among E-cadherin-expressing tumours. The gene discussed is EPCAM; the disease is colorectal carcinoma.